TATDN1 Polyclonal antibody

• 

  WB analysis using 31840-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 31840-1-AP (TATDN1 antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

TATDN1 Polyclonal Antibody for WB, ELISA

Cat No. 31840-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

Synonyms

TatD DNase Domain Containing 1 , Deoxyribonuclease TATDN1, CDA11

---

Tested Applications

• Positive WB detected in: A431 cells, A431 cell, A549 cell

Recommended dilution

• Western Blot (WB): WB : 1:1000-1:4000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, Check data in validation data gallery.

Product Information

31840-1-AP targets TATDN1 in WB, ELISA applications and shows reactivity with human samples.

• Tested Reactivity: human
• Host / Isotype: Rabbit / IgG
• Class: Polyclonal
• Type: Antibody
• Immunogen: TATDN1 fusion protein Ag36040
• Full Name: TatD DNase domain containing 1
• Observed Molecular Weight: 30 kDa
• GenBank Accession Number: BC064964
• Gene Symbol: TATDN1
• Gene ID (NCBI): 83940
• RRID: AB_3670124
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Antigen affinity Purification
• UNIPROT ID: Q6P1N9
• Storage Buffer: PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
• Storage Conditions: Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20^oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Homo sapiens TatD DNase domain containing 1 (TATDN1), a member of the TATD family, is a highly conserved nuclease in both prokaryotes and eukaryotes with depurine/apyrimidine (AP) endonuclease activity, which plays an extremely important role in the genesis and prognosis of malignant tumors such as NSCLC and breast cancer, and is a potential therapeutic target for NSCLC patients who have failed to undergo cisplatin therapy (DDP) in vivo.